Kansas City Star

GSK expects first doses of Ebola vaccine ready by year end
Financial Times
GlaxoSmithKline said it expected to have the first doses of its experimental Ebola vaccine ready by the end of this year, as Johnson & Johnson pledged to invest up to $200m to accelerate another vaccine for the virus ravaging west Africa. Sir Andrew Witty ...
Drugmaker commits $200M to speed up Ebola vaccineNew York Post
Johnson & Johnson plans Ebola vaccine testingBoston Herald
J&J gives the Ebola vaccine push a $200M boostFierceBiotech
Asbury Park Press -StreetInsider.com (subscription) -International Business Times
all 201 news articles »